These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3472031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
    Francoual M.
    Nouv Presse Med; 1979 Jan 23; 8(4):293-6. PubMed ID: 122024
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Organic nitrate and vasodilator therapy of cardiac insufficiency].
    Strauer BE.
    Verh Dtsch Ges Inn Med; 1979 Jan 23; 83():154-70. PubMed ID: 417497
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of acute and chronic congestive heart failure by vasodilator-afterload reduction.
    Mason DT, Awan NA, Joye JA, Lee G, DeMaria AN, Amsterdam EA.
    Arch Intern Med; 1980 Dec 23; 140(12):1577-81. PubMed ID: 6257193
    [No Abstract] [Full Text] [Related]

  • 7. [Mechanism of action and clinical use of vasodilators in acute heart insufficiency].
    Rothlin ME.
    Schweiz Rundsch Med Prax; 1985 Dec 03; 74(49):1372-5. PubMed ID: 4081449
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Action of oxyphedrine on ventricular dynamics in ischemic cardiopathy].
    Barbosa J, Lopes AS, Lopes JS, Vergara M, Benchimol AB.
    Arq Bras Cardiol; 1972 Jun 03; 25(3):231-9. PubMed ID: 5079398
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
    Hayase S, Hirakawa S, Hosokawa S, Mori N, Kanyama S.
    Arzneimittelforschung; 1972 Feb 03; 22(2):370-3. PubMed ID: 4554632
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cardiac and extracardiac parameters as principles in differential therapeutic considerations for decreasing pre- and afterload].
    Kramer W.
    Z Kardiol; 1988 Feb 03; 77 Suppl 5():87-96. PubMed ID: 3066043
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Long-term use of vasodilator agents].
    Luomanmaki K, Frick MH.
    Duodecim; 1982 Feb 03; 98(2):139-49. PubMed ID: 7060511
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vasodilator therapy for chronic heart failure.
    Mason DT, Awan NA, Demaria AN, Lee G, Joye JA, Amsterdam EA.
    Compr Ther; 1979 Jul 03; 5(7):6-14. PubMed ID: 383392
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vasodilators in left ventricular failure.
    Camerini F, Mestroni L, Neri R, Humar F.
    G Ital Cardiol; 1984 Sep 03; 14(9):685-93. PubMed ID: 6510623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.